LeukoPrint - SeekIn

LeukoPrint^®
The first-in-class leukemia sWGS CNA test

By evaluating the copy number aberration (CNA) in bone marrow cells and/or circulating cell free DNA (cfDNA) via shallow whole genome sequencing (sWGS), in conjunction with conventional cytogenetics, LeukoPrint^® makes leukemia diagnosis, molecular subtyping, prognostic stratification and treatment responds monitoring more precise and comprehensive.
High sensitivity and low failure rate
Automatic readout system
Without culturing cells in vitro
Specifications

◉ Sample requirement：1-2ml bone marrow or 10ml blood
◉ TAT：10 work days
◉ Result readout：copy number aberration（CNA）
◉ Indicated subjects：Patients with suspected or confirmed leukemia (MDS/AML/ALL/CLL/MM)
Test Workflow

1
Pre-test inquiry
2
Informed consent
3
Sampling
4
Testing
5
Analyzing + Interpretation
6
Reporting
7
Post-test consultation
REQUEST THE TEST

©2018 SeekIn Cancer. All Rights Reserved.